MXPA03005526A - Antagonistas ccr5 y polipeptido dp-178 para el tratamiento de infecciones virales. - Google Patents

Antagonistas ccr5 y polipeptido dp-178 para el tratamiento de infecciones virales.

Info

Publication number: MXPA03005526A
Authority: MX; Mexico
Prior art keywords: viral infections; combination method; treating viral; treating; combination
Prior art date: 2000-12-19

Application number

MXPA03005526A

Other languages

English (en)

Inventor

M Baroudy Bahige

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-19

Filing date

2001-12-17

Publication date

2003-10-06

2001-12-17 Application filed by Schering Corp filed Critical Schering Corp

2003-10-06 Publication of MXPA03005526A publication Critical patent/MXPA03005526A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

MXPA03005526A 2000-12-19 2001-12-17 Antagonistas ccr5 y polipeptido dp-178 para el tratamiento de infecciones virales. MXPA03005526A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US25665700P	2000-12-19	2000-12-19
PCT/US2001/048802 WO2002056902A2 (en)	2000-12-19	2001-12-17	Ccr5 antagonist and dp-178 polypeptide for treating viral infections

Publications (1)

Publication Number	Publication Date
MXPA03005526A true MXPA03005526A (es)	2003-10-06

Family

ID=22973061

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA03005526A MXPA03005526A (es)	2000-12-19	2001-12-17	Antagonistas ccr5 y polipeptido dp-178 para el tratamiento de infecciones virales.

Country Status (12)

Country	Link
US (1)	US20050065319A1 (es)
EP (1)	EP1385534A2 (es)
JP (1)	JP2005500981A (es)
CN (1)	CN1481251A (es)
AR (1)	AR031931A1 (es)
BR (1)	BR0116253A (es)
CA (1)	CA2431919A1 (es)
HU (1)	HUP0302241A3 (es)
MX (1)	MXPA03005526A (es)
NO (1)	NO20032769L (es)
WO (1)	WO2002056902A2 (es)
ZA (1)	ZA200304560B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2400553A (en) *	2003-04-14	2004-10-20	Cipla Ltd	Antiviral pharmaceutical combination of lamivudine, stavudine and efavirenz, or derivatives thereof
BRPI0410360A (pt) *	2003-05-16	2006-08-01	Univ Maryland Biotech Inst	composições para a sub-regulação da expressão de ccr5 e métodos para seu uso
CA2587903A1 (en)	2004-11-17	2006-05-26	Amgen Fremont Inc.	Fully human monoclonal antibodies to il-13
JP2009517474A (ja) *	2005-11-30	2009-04-30	シェーリングコーポレイション	Ｃｃｒ５拮抗剤およびｃｘｃｒ４拮抗剤の組み合わせを含む組成物
EP1976497A2 (en) *	2005-12-01	2008-10-08	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Treatment of viral infections
EP1886696A1 (en) *	2006-08-03	2008-02-13	Endotis Pharma	Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
WO2013127299A1 (zh) *	2012-02-28	2013-09-06	中国人民解放军军事医学科学院毒物药物研究所	用于抑制hiv的多肽及其作用靶点
US11629196B2 (en)	2020-04-27	2023-04-18	Incelldx, Inc.	Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5464933A (en) *	1993-06-07	1995-11-07	Duke University	Synthetic peptide inhibitors of HIV transmission
CA2224008C (en) *	1995-06-07	2009-08-18	Trimeris, Inc.	The treatment of hiv and other viral infections using combinatorial therapy
US6281331B1 (en) *	1998-03-23	2001-08-28	Trimeris, Inc.	Methods and compositions for peptide synthesis
CA2365900A1 (en) *	1999-05-04	2000-11-09	Schering Corporation	Pegylated interferon alfa-ccr5 antagonist combination hiv therapy
US6391865B1 (en) *	1999-05-04	2002-05-21	Schering Corporation	Piperazine derivatives useful as CCR5 antagonists
US6689765B2 (en) *	1999-05-04	2004-02-10	Schering Corporation	Piperazine derivatives useful as CCR5 antagonists
PT1175402E (pt) *	1999-05-04	2005-11-30	Schering Corp	Derivados da piperidina uteis como antagonistas ccr5
US6387930B1 (en) *	1999-05-04	2002-05-14	Schering Corporation	Piperidine derivatives useful as CCR5 antagonists

2001
- 2001-06-11 US US10/168,295 patent/US20050065319A1/en not_active Abandoned
- 2001-12-17 BR BRPI0116253-5A patent/BR0116253A/pt not_active IP Right Cessation
- 2001-12-17 EP EP01993303A patent/EP1385534A2/en not_active Withdrawn
- 2001-12-17 MX MXPA03005526A patent/MXPA03005526A/es unknown
- 2001-12-17 CA CA002431919A patent/CA2431919A1/en not_active Abandoned
- 2001-12-17 HU HU0302241A patent/HUP0302241A3/hu unknown
- 2001-12-17 AR ARP010105840A patent/AR031931A1/es unknown
- 2001-12-17 CN CNA01820919XA patent/CN1481251A/zh active Pending
- 2001-12-17 JP JP2002557409A patent/JP2005500981A/ja active Pending
- 2001-12-17 WO PCT/US2001/048802 patent/WO2002056902A2/en not_active Ceased
2003
- 2003-06-11 ZA ZA2003/04560A patent/ZA200304560B/en unknown
- 2003-06-18 NO NO20032769A patent/NO20032769L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20032769L (no)	2003-08-18
HUP0302241A2 (hu)	2003-11-28
US20050065319A1 (en)	2005-03-24
WO2002056902A3 (en)	2002-12-05
WO2002056902A2 (en)	2002-07-25
CA2431919A1 (en)	2002-07-25
ZA200304560B (en)	2005-07-27
BR0116253A (pt)	2006-05-02
EP1385534A2 (en)	2004-02-04
CN1481251A (zh)	2004-03-10
JP2005500981A (ja)	2005-01-13
HUP0302241A3 (en)	2005-06-28
NO20032769D0 (no)	2003-06-18
AR031931A1 (es)	2003-10-08

Publication	Publication Date	Title
MXPA03005445A (es)	2003-09-10	Barra colectora 12c para aislar los circuitos integrados seleccionados para una comunicacion rapida de barra colectora 12c.
EP1128832A4 (en)	2003-03-05	COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND RELATED DISEASES
MXPA03002410A (es)	2003-06-19	4-amino-quinazolinas.
ZA200210206B (en)	2004-03-17	Expression system.
ZA200209047B (en)	2003-05-23	Process for permanently reshaping the hair using particular aminosilicones.
ZA200300447B (en)	2004-02-25	Granulation process.
MXPA02000893A (es)	2003-07-14	Pasteurizador.
EG23262A (en)	2004-10-31	Delta -pyrrolines.
GC0000155A (en)	2005-06-29	6-Hydroxy-indazole derivatives for treating glaucoma.
MXPA03001710A (es)	2003-09-22	Metodo de limpieza.
MXPA03001591A (es)	2003-09-10	Derivados y analogos de 10-aril-11-h-benzo(b) fluorena para uso medicinal.
ZA200306040B (en)	2004-11-17	Hepatitis B virus treatment.
AP2004002968A0 (en)	2004-03-31	Single dose azithromycin for treating respiratory infections.
MXPA03006607A (es)	2003-09-22	Metodo combinado para tratar trastornos dependientes de hormonas.
MXPA03001877A (es)	2003-06-24	2-guanidin-4-arilquinazolinas.
MXPA03002668A (es)	2003-08-20	Guanidinas de sulfonilo.
MXPA03003347A (es)	2003-06-19	Procedimiento para purificacion de pravastatina.
MXPA03002411A (es)	2003-06-19	4-amino-quinazolinas.
MXPA03005714A (es)	2003-10-06	Sulfamidotienopirimidinas.
MXPA03005526A (es)	2003-10-06	Antagonistas ccr5 y polipeptido dp-178 para el tratamiento de infecciones virales.
MXPA01010008A (es)	2003-08-20	Metodos para promover la piel clara.
MXPA03005569A (es)	2003-10-06	PROCEDIMIENTO MEJORADO PARA LA PREPARACION DE UN FARMACO ANTIMIGRAnOSO.
MXPA03005494A (es)	2003-10-06	Benzoilpiridazinas.
MXPA03002521A (es)	2004-02-12	Triazol-epotilona.
GB0123898D0 (en)	2001-11-28	Method for treating objects